Skip to main content
SpringerLink
Log in

OPC 14117

  • Section 1: Neuroprotection in Stroke
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Huntington Study Group. Safety and tolerability of the freeradical scavenger OPC-14117 in Huntington’s disease. Neurology 1998 May; 50: 1366–73

    Article  Google Scholar 

  2. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. Neurology 1997 Jul; 49: 142–6

    Article  Google Scholar 

  3. Prous J, Mealy N, Castañer J. OPC-14117. Neuronal injury inhibitor, lipid peroxidation inhibitor. Drugs Future 1993 Aug; 18: 707–10

    Google Scholar 

  4. Uwahodo Y, Kikuchi T, Tottori K, et al. Improving effects of OPC-14117 on disturbance of consciousness in the experimental head injury models. Jpn J Pharmacol 1996; 71 Suppl. I: 271

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

OPC 14117. Drugs R&D 1, 34–35 (1999). https://doi.org/10.2165/00126839-199901010-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901010-00013

Keywords

Search

Navigation